Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...
Altria just rewarded its shareholders again with a dividend. This high-yield stock has boosted its payout annually for more ...
The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application ...
In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price ...
Altria Group, Inc. (MO), headquartered in Richmond, Virginia, is a leading producer and seller of smokeable and oral tobacco ...
For decades, tobacco companies have tried to develop alternative ... The product competes with similar ones from competitors, including Altria’s On pouches. The Associated Press Health and ...